FDA investigating severe hypocalcemia in dialysis patients on Prolia
Nov 22 - Increase calcium supplementation and blood level monitoring
Drugs
The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States
Topic Paragraphs
Recent News
FDA issues Federal Register Notice regarding access to naloxone products
Nov 15 - Assesses certain products may be safe and effective for over-the-counter use
FDA alerts health care professionals of risks to patients exposed to xylazine
Nov 8 - Naloxone may not be effective in reversing overdoses involving xylazine
Upcoming Events
FDA to discuss new prescription drugs labeling resources for industry
Webpages will feature searchable labeling, product databases and more
FDA to describe Individual Case Study Reports specifications and process
Event to discuss methods and paths for submission to FAERS
FDA provides overview of compounding post-inspection expectations
Webinar addresses Form 483 responses, examples, closeout meetings and more
Trending Topics
Disposal of Unused Medicines: What You Should Know
The short video shows you how to properly get rid of unused or expired medication
High Blood Pressure–Understanding the Silent Killer
It can lead to many serious problems that’s why it’s important to know your risk factors
BeSafeRx: Your Source for Online Pharmacy Information
Explore resources and tools so you can safely buy prescription medicines online
CENTER FOR DRUG EVALUATION AND RESEARCH
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.